Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02736825 · ClinicalTrials.gov registry record · NA
Simulines Non-Inferiority Pivotal Study
A NA study, sponsored by Ulthera.
- Terminated
- Registry status
- NA
- Development phase
- 262
- Enrollment target
NCT02736825 is a NA study that was terminated before completion, run by Ulthera. The registered enrollment target is 262 participants.
The verdict
NCT02736825, a NA study, was terminated before completion, sponsored by Ulthera.
- TERMINATED
- Registry status
- NA
- Development phase
- 262 participants
- Enrollment target
Study Summary
Up to 260 subjects presenting with skin laxity on the face and neck will be randomized to one of two treatment groups. Subjects meeting all entrance criteria will receive study treatment, then complete two post treatment phone contacts and follow-up study visits at 90, 180 and 365 days post treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit for qualitative and quantitative assessments of efficacy.
Interventions
- DEVICE Ulthera System with standard transducer
- DEVICE Ulthera System with prototype 2 simulines transducer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2016-04-11 |
| Est. Completion | 2017-04-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02736825
The ClinicalTrials.gov registry entry for NCT02736825 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ulthera System with standard transducer is the first listed.
NCT02736825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02736825 about?
NCT02736825 is a clinical study titled "Simulines Non-Inferiority Pivotal Study". Up to 260 subjects presenting with skin laxity on the face and neck will be randomized to one of two treatment groups. Subjects meeting all entrance criteria will receive study treatment, then complete two post treatment phone contacts and follow-up study visits at 90, 180 and 365 days post treatmen...
What is the current status of trial NCT02736825?
This trial is currently terminated. It is a NA study. The enrollment target is 262 participants. The study started on 2016-04-11. Estimated completion is 2017-04-25.
What interventions are being tested in trial NCT02736825?
The interventions under investigation include: Ulthera System with standard transducer (DEVICE), Ulthera System with prototype 2 simulines transducer (DEVICE).
Who is sponsoring clinical trial NCT02736825?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.